Protective Effects of Caffeine and Artemisinin against Initiation of Breast Tumour in 7, 12-Dimethylbenzanthracene treated Albino Rats


  • Titilope M. Dokunmu Department of Biochemistry, Covenant University, Ota, Nigeria
  • David O. Enoma Department of Biochemistry, Covenant University, Ota, Nigeria
  • Sandra C. Opara Department of Biochemistry, Covenant University, Ota, Nigeria
  • Omiete U Awani Department of Biochemistry, Covenant University, Ota, Nigeria
  • Omolara F. Yakubu Department of Biochemistry, Covenant University, Ota, Nigeria
  • Michael O. Ezekiel Department of Biochemistry, Covenant University, Ota, Nigeria
  • Oluwakemi A. Rotimi Department of Biochemistry, Covenant University, Ota, Nigeria
  • Solomon O. Rotimi Department of Biochemistry, Covenant University, Ota, Nigeria
  • Abiodun H. Adebayo Department of Biochemistry, Covenant University, Ota, Nigeria


Breast tumour, DMBA, Caffeine, Artemisinin, DNA damage


Breast cancer is the most diagnosed cancer in women and it causes high cancer-related deaths globally. Cancer prevention strategies for breast cancer are limited hence remedies that have protective effects against the initiation of carcinogenesis are relevant. This study evaluated inhibition and effects on breast cancer by artemisinin and caffeine. Tumor development in 35 female albino rats after a dose of 40 mg/kg of 7,12-dimethylbenzanthracene (DMBA) and effects on DNA damage in breast tissues was assessed using comet assay and histology studies after 5weeks of daily administration of 25 mg/kg caffeine, 4mg/kg artemisinin or combination of both. Comet scores in treated groups were compared with positive and negative controls, at a significance level of p < 0.05. A mammary tumor was observed in negative control group after 54 days. Caffeine-artemisinin combination and artemisinin showed a very mild degree of DNA damage compared to the positive control. Comet values in Caffeine-artemisinin, negative control was 0.83%, 3.19%, respectively. Histopathological analyses of mammary tissues showed no evidence of neoplasm which correlated with DNA damage levels and the absence of tumor. Combination of artemisinin and caffeine may reduce the risk of developing breast cancer by inhibiting initiation, promotion and progression which is crucial for reducing cancer morbidities.


Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394-424.

Weir HK, Thompson TD, Soman A, Moller B, Leadbetter S. The past, present, and future of cancer incidence in the United States: 1975 through 2020. Cancer. 2015; 121: 1827-1837.

Richardson LC, Henley SJ, Miller JW, Massetti G, Thomas CC. Pattern and trends in age-specific black-white differences in breast cancer incidence and mortality –United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2016; 65:1093-1098.

Pitt JJ, Riester M, Zheng Y, Yoshimatsu TF, Sanni A, Oluwasola O, Veloso A, Labrot E, Wang S, Odetunde A, Ademola A, Okedere B, Mahan S, Leary R, Macomber M, Ajani M, Johnson RS, Fitzgerald D, Grundstad AJ, Tuteja JH, Khramtsova G, Zhang J, Sveen E, Hwang B, Clayton

W, Nkwodimmah C, Famooto B, Obasi E, Aderoju V, Oludara M, Omodele F, Akinyele O, Adeoye A, Ogundiran T, Babalola C, MacIsaac K, Popoola A, Morrissey MP, Chen LS, Wang J, Olopade CO, Falusi AG, Winckler W, Haase K, Van Loo P, Obafunwa J, Papoutsakis D,

Ojengbede O, Weber B, Ibrahim N, White KP, Huo D, Olopade OI, Barretina J. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nat Commun. 2018; 9:4181.

Chung FL, Wang M, Rivenson A, Iatropoulos MJ, Reinhardt JC, Pittman B, Ho CT, Amin SG. Inhibition of Lung Carcinogenesis by Black Tea in Fischer Rats Treated with a Tobacco-specific Carcinogen: Caffeine as an Important Constituent. Cancer Res. 1998; 58:4096-4101.

Hu R, Saw CL, Yu R, Kong AT. Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory. Antioxid Redox Signal. 2010; 13:1679-1698.

Lai H and Singh NP. Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. Cancer Lett. 2006; 231:43-48.

von Hagens C, Walter-Sack I, Goeckenjan M, StorchHagenlocher B, Sertel S, Elsässer M, Remppis BA, Munzinger J, Edler L, Efferth T, Schneeweiss A, Strowitzki T. Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2). Phytomed. 2019; 54:140-148.

Zhang ZY, Yu SQ, Miao LY, Huang XY, Zhang XP, Zhu YP, Xia XH, Li DQ. Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: A randomized controlled trial. J Chin Integr Med. 2008; 6:134-138.

Fox JM, Moynihan JR, Mott BT, Mazzone JR, Anders NM, Brown PA, Rudek MA, Liu JO, Arav-Boger R, Posner GH, Civin CI, Chen X. Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs. Oncotarget. 2016; 7:7268-7279

Drenberg CD, Buaboonnam J, Orwick SJ, Hu S, Li L, Fan Y, Shelat AA, Guy RK, Rubnitz J, Baker SD. Evaluation of artemisinins for the treatment of acute myeloid leukemia. Cancer Chemother Pharmacol. 2016; 77:1231-1243

Mao H, Gu H, Qu X, Sun J, Song B, Gao W, Liu J, Shao Q. Involvement of the mitochondrial pathway and Bim/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro. Int J Mol Med. 2013; 31:213-218.

Wang G, Bhoopalan V, Wang D, Wang L, Xu X. The effect of caffeine on cisplatin-induced apoptosis of lung cancer cells. Exp Hematol Oncol. 2015; 4(1):5.

Wolfrom DM 1991. Caffeine inhibits development of benign mammary gland tumors in carcinogen-treated female Sprague-Dawley rats. J Breast Cancer Res Treat. 991; 19:269–275.

Enoma DO, Dokunmu TM, Obi P. The Anticancer Activity of Caffeine - A Review. Arch Clin Biomed Res. 2019; 3: 326-342

Bode AM, Dong Z. The enigmatic effects of caffeine in cell cycle and cancer. Cancer Letters. 2007; 247:26-39.

Verma S, Das P, Kumar, VL. Chemoprevention by artesunate in a preclinical model of colorectal cancer involves down regulation of β-catenin, suppression of angiogenesis, cellular proliferation and induction of apoptosis. Chemico-Biological Interact. 2017; 278:84-91.

Lin R, Zhang Z, Chen L, Zhou Y, Zou P, Feng C, Wang L, Liang G. Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells. Cancer Lett. 2016; 381:165-175.

Huang M-T, Xie J-G, Wang ZY, Ho C-T, Lou Y-R, Wang C-X, Hard GC, Conney AH. Effects of Tea, Decaffeinated Tea, and Caffeine on UVB Light-induced Complete Carcinogenesis in SKH-1 Mice: Demonstration of Caffeine as a Biologically Important Constitutent of Tea. Cancer

Res. 1997; 57:2623-2629.

Kerzendorfer C, O’Driscoll M. UVB and Caffeine: Inhibiting the DNA Damage Response to Protect Against the Adverse Effects of UVB. J Invest Dermatol. 2009; 129: 1611-1613.

Wang Z, Zhang L, Wan Z. He Y, Huang H, Wu X, Zhang K, Liu Y, Goodin S, Du Z, Zheng X. Atorvastatin and Caffeine in Combination Regulates Apoptosis, Migration, Invasion and Tumorspheres of Prostate Cancer Cells. Pathol Oncol Res. 2020; 26:209-216.

Cheng Y-C, Ding Y-M, Hueng D-Y, Chen J-Y, Chen Y. Caffeine suppresses the progression of human glioblastomaviacathepsin B and MAPK signaling pathway. J Nutr Biochem. 2016; 33:63-72.

Olive PL, Banáth JP. The comet assay: a method to measure DNA damage in individual cells. Nature Protocols. 2006; 1: 23.

Gyori BM, Venkatachalam G, Thiagarajan PS, Hsu D, Clement MV. OpenComet: An automated tool for comet assay image analysis. Redox Biol. 2014; 2:457-465.

Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893-2917.

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2):87-108

Gunasekarana V, Raj GV, Chand P. A comprehensive review on clinical applications of comet assay. J Clin Diagnos Res. 2015; 9(3):GE01-GE05.

Higuchi T, Kawaguchi K, Miyake K. Oral Recombinant Methioninase Combined with Caffeine and Doxorubicin Induced Regression of a Doxorubicin-resistant Synovial Sarcoma in a PDOX Mouse Model. Anticancer Res. 2018; 38: 5639-5644.

Eini H, Frishman V, Yulzari R, Kachko L, Lewis EC, Chaimovitz C, Douvdevani A. Caffeine promotes antitumor immune response during tumor initiation: Involvement of the adenosine A2A receptor. Biochem Pharmacol. 2015; 98(1): 110-118.

Tao KS, Wang W, Wang L, Cao DY, Li YQ, Wu SX, Dou KF. The multifaceted mechanisms for coffee’s antitumorigenic effect on liver. Med Hypotheses. 2008; 71:730-736.

Li Z, Li Q, Wu J, Wang M, Yu J. Artemisinin and Its Derivatives as a repurposing anticancer agent: What else do we need to do? Molecules. 2016; 21:1331.




How to Cite

Dokunmu, T. M., Enoma, D. O., Opara, S. C., Awani, O. U., Yakubu, O. F., Ezekiel, M. O., … Adebayo, A. H. (2020). Protective Effects of Caffeine and Artemisinin against Initiation of Breast Tumour in 7, 12-Dimethylbenzanthracene treated Albino Rats: Tropical Journal of Natural Product Research (TJNPR), 4(12), ):1161–1165. Retrieved from

Most read articles by the same author(s)

1 2 > >>